世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034117

間質性膀胱炎治療薬の世界市場(2023-2027)

TechNavio

Global Interstitial Cystitis Drugs Market 2023-2027

発刊日 2023/01/04

言語英語

体裁PDF/160ページ

ライセンス/価格160ページ

0000034117

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、間質性膀胱炎治療薬市場を分析します。

世界の間質性膀胱炎治療薬市場は、予測期間中に約5.9 %のCAGRで推移し、2022年から2027年の間に3億6,958万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。間質性膀胱炎の有病率の高さ、間質性膀胱炎に対する認知度の向上、間質性膀胱炎に関する研究助成の増加などが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ タイプ別
      ◇ 経口治療
      ◇ 膀胱内治療
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ オンライン薬局
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、遺伝子治療の登場が、今後数年間の間質性膀胱炎治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、患者支援プログラムや薬剤の承認の増加が、市場の大きな需要につながると考えています。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • 間質性膀胱炎治療薬の市場規模
  • 間質性膀胱炎治療薬の市場予測
  • 間質性膀胱炎治療薬市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な間質性膀胱炎治療薬市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Allergan
    ➣ Amneal Pharmaceuticals Inc.
    ➣ Astellas Pharma Inc.
    ➣ Aurobindo Pharma Ltd.
    ➣ Bayer AG
    ➣ Cadila Healthcare Ltd.
    ➣ Eli Lilly and Co.
    ➣ Hikma Pharmaceuticals Plc
    ➣ Intas Pharmaceuticals Ltd.
    ➣ Johnson and Johnson
    ➣ キョーリン製薬(Kyorin Pharmaceutical Co. Ltd.)
    ➣ Mission Pharmacal Co.
    ➣ Perrigo Co. Plc
    ➣ Pfizer Inc.
    ➣ Purdue Pharma LP
    ➣ 生化学工業(Seikagaku Corp.)
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Taro Pharmaceutical Industries Ltd.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global interstitial cystitis drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global interstitial cystitis drugs market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Distribution channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Oral therapy - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oral therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oral therapy - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral therapy - Year-over-year growth 2022-2027 (%)
6.4 Intravesical therapy - Market size and forecast 2022-2027
Exhibit 38: Chart on Intravesical therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Intravesical therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Intravesical therapy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Intravesical therapy - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 43: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 44: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 45: Chart on Comparison by Distribution Channel
Exhibit 46: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2022-2027
Exhibit 47: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacies - Market size and forecast 2022-2027
Exhibit 51: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
7.5 Online pharmacies - Market size and forecast 2022-2027
Exhibit 55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 59: Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 61: Chart on Market share by geography 2022-2027 (%)
Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 101: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 Allergan
Exhibit 108: Allergan - Overview
Exhibit 109: Allergan - Product / Service
Exhibit 110: Allergan - Key offerings
12.4 Amneal Pharmaceuticals Inc.
Exhibit 111: Amneal Pharmaceuticals Inc. - Overview
Exhibit 112: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 113: Amneal Pharmaceuticals Inc. - Key news
Exhibit 114: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 115: Amneal Pharmaceuticals Inc. - Segment focus
12.5 Astellas Pharma Inc.
Exhibit 116: Astellas Pharma Inc. - Overview
Exhibit 117: Astellas Pharma Inc. - Product / Service
Exhibit 118: Astellas Pharma Inc. - Key offerings
12.6 Bayer AG
Exhibit 119: Bayer AG - Overview
Exhibit 120: Bayer AG - Business segments
Exhibit 121: Bayer AG - Key news
Exhibit 122: Bayer AG - Key offerings
Exhibit 123: Bayer AG - Segment focus
12.7 Cadila Healthcare Ltd.
Exhibit 124: Cadila Healthcare Ltd. - Overview
Exhibit 125: Cadila Healthcare Ltd. - Business segments
Exhibit 126: Cadila Healthcare Ltd. - Key offerings
Exhibit 127: Cadila Healthcare Ltd. - Segment focus
12.8 Eli Lilly and Co.
Exhibit 128: Eli Lilly and Co. - Overview
Exhibit 129: Eli Lilly and Co. - Product / Service
Exhibit 130: Eli Lilly and Co. - Key offerings
12.9 Johnson and Johnson
Exhibit 131: Johnson and Johnson - Overview
Exhibit 132: Johnson and Johnson - Business segments
Exhibit 133: Johnson and Johnson - Key news
Exhibit 134: Johnson and Johnson - Key offerings
Exhibit 135: Johnson and Johnson - Segment focus
12.10 Kyorin Pharmaceutical Co. Ltd.
Exhibit 136: Kyorin Pharmaceutical Co. Ltd. - Overview
Exhibit 137: Kyorin Pharmaceutical Co. Ltd. - Product / Service
Exhibit 138: Kyorin Pharmaceutical Co. Ltd. - Key offerings
12.11 Perrigo Co. Plc
Exhibit 139: Perrigo Co. Plc - Overview
Exhibit 140: Perrigo Co. Plc - Business segments
Exhibit 141: Perrigo Co. Plc - Key news
Exhibit 142: Perrigo Co. Plc - Key offerings
Exhibit 143: Perrigo Co. Plc - Segment focus
12.12 Pfizer Inc.
Exhibit 144: Pfizer Inc. - Overview
Exhibit 145: Pfizer Inc. - Product / Service
Exhibit 146: Pfizer Inc. - Key news
Exhibit 147: Pfizer Inc. - Key offerings
12.13 Seikagaku Corp.
Exhibit 148: Seikagaku Corp. - Overview
Exhibit 149: Seikagaku Corp. - Business segments
Exhibit 150: Seikagaku Corp. - Key offerings
Exhibit 151: Seikagaku Corp. - Segment focus
12.14 Sun Pharmaceutical Industries Ltd.
Exhibit 152: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 153: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 154: Sun Pharmaceutical Industries Ltd. - Key offerings
12.15 Taro Pharmaceutical Industries Ltd.
Exhibit 155: Taro Pharmaceutical Industries Ltd. - Overview
Exhibit 156: Taro Pharmaceutical Industries Ltd. - Product / Service
Exhibit 157: Taro Pharmaceutical Industries Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 158: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 163: Viatris Inc. - Overview
Exhibit 164: Viatris Inc. - Business segments
Exhibit 165: Viatris Inc. - Key offerings
Exhibit 166: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global interstitial cystitis drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Oral therapy - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral therapy - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral therapy - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral therapy - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Intravesical therapy - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Intravesical therapy - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Intravesical therapy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Intravesical therapy - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits44: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Distribution Channel
Exhibits46: Data Table on Comparison by Distribution Channel
Exhibits47: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Distribution Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2022-2027 (%)
Exhibits62: Data Table on Market share by geography 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity by geography ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Allergan - Overview
Exhibits109: Allergan - Product / Service
Exhibits110: Allergan - Key offerings
Exhibits111: Amneal Pharmaceuticals Inc. - Overview
Exhibits112: Amneal Pharmaceuticals Inc. - Business segments
Exhibits113: Amneal Pharmaceuticals Inc. - Key news
Exhibits114: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits115: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits116: Astellas Pharma Inc. - Overview
Exhibits117: Astellas Pharma Inc. - Product / Service
Exhibits118: Astellas Pharma Inc. - Key offerings
Exhibits119: Bayer AG - Overview
Exhibits120: Bayer AG - Business segments
Exhibits121: Bayer AG - Key news
Exhibits122: Bayer AG - Key offerings
Exhibits123: Bayer AG - Segment focus
Exhibits124: Cadila Healthcare Ltd. - Overview
Exhibits125: Cadila Healthcare Ltd. - Business segments
Exhibits126: Cadila Healthcare Ltd. - Key offerings
Exhibits127: Cadila Healthcare Ltd. - Segment focus
Exhibits128: Eli Lilly and Co. - Overview
Exhibits129: Eli Lilly and Co. - Product / Service
Exhibits130: Eli Lilly and Co. - Key offerings
Exhibits131: Johnson and Johnson - Overview
Exhibits132: Johnson and Johnson - Business segments
Exhibits133: Johnson and Johnson - Key news
Exhibits134: Johnson and Johnson - Key offerings
Exhibits135: Johnson and Johnson - Segment focus
Exhibits136: Kyorin Pharmaceutical Co. Ltd. - Overview
Exhibits137: Kyorin Pharmaceutical Co. Ltd. - Product / Service
Exhibits138: Kyorin Pharmaceutical Co. Ltd. - Key offerings
Exhibits139: Perrigo Co. Plc - Overview
Exhibits140: Perrigo Co. Plc - Business segments
Exhibits141: Perrigo Co. Plc - Key news
Exhibits142: Perrigo Co. Plc - Key offerings
Exhibits143: Perrigo Co. Plc - Segment focus
Exhibits144: Pfizer Inc. - Overview
Exhibits145: Pfizer Inc. - Product / Service
Exhibits146: Pfizer Inc. - Key news
Exhibits147: Pfizer Inc. - Key offerings
Exhibits148: Seikagaku Corp. - Overview
Exhibits149: Seikagaku Corp. - Business segments
Exhibits150: Seikagaku Corp. - Key offerings
Exhibits151: Seikagaku Corp. - Segment focus
Exhibits152: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits153: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits154: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits155: Taro Pharmaceutical Industries Ltd. - Overview
Exhibits156: Taro Pharmaceutical Industries Ltd. - Product / Service
Exhibits157: Taro Pharmaceutical Industries Ltd. - Key offerings
Exhibits158: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits159: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits160: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits161: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits162: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits163: Viatris Inc. - Overview
Exhibits164: Viatris Inc. - Business segments
Exhibits165: Viatris Inc. - Key offerings
Exhibits166: Viatris Inc. - Segment focus
Exhibits167: Inclusions checklist
Exhibits168: Exclusions checklist
Exhibits169: Currency conversion rates for US$
Exhibits170: Research methodology
Exhibits171: Validation techniques employed for market sizing
Exhibits172: Information sources
Exhibits173: List of abbreviations

この商品のレポートナンバー

0000034117

TOP